Abstract
INTRODUCTION
Non-alcoholic fatty liver disease (NAFLD) is emerging as a leading cause of chronic liver disease in children and adolescents, with a prevalence in the general population ranging from 3%-10% in normal weight children and 80% in obese children [1] [2] . Children with NAFLD are usually asymptomatic and garner clinical attention because of elevated liver enzymes or fatty liver being observed during an ultrasound examination. The measurement of liver enzymes alone is not sufficient for accurate fatty liver screening in overweight children because enzymatic abnormalities correlates poorly or not at all with early steatosis [3, 4] . At present, liver biopsy represents the reference standard for diagnosing liver steatosis, although the drawbacks of this invasive technique are well known. It is associated with morbidity and mortality, it has sampling errors, and it is not appropriate for screening, longitudinal monitoring, or evaluating treatment response [4] . Among the currently available imaging modalities, magnetic resonance imaging (MRI) and ¹ H MR spectroscopy (MRS) are the most reproducible, safe, and accurate imaging techniques that can be used in clinical trials and epidemiologic studies [5] .
However, MRS has limited clinical applicability or availability because it requires sophisticated postprocessing methods, and not every MRI is routinely equipped with MRS capabilities. Recent improvements in MRI can provide the magnetic resonance imagingestimated proton density fat fraction (MRI-PDFF), which is a novel biomarker that has demonstrated robust correlation and equivalency with MRS [6] [7] [8] [9] [10] .
In addition, MRI-PDFF allows fat mapping of the entire liver, and it can be used with any clinical MRI platform, whereas MRS measures fat biochemically in small regions of interest (ROIs). To the best of our knowledge, few studies have used MRS and histology to investigate liver fat content in adolescents [11] [12] [13] [14] . A recently published paper suggested similar fatstorage between overweight children and adults, and the study proposed the same cut-off value for normal and pathologic storage [15] . The aim of our study was to validate a cut-off value for a pediatric population and to correlate the data with laboratory/chemistry results and subcutaneous and visceral adipose tissue (SAT and VAT) findings.
MATERIALS AND METHODS
The study has been approved by the ethics committee, and written informed consent was obtained from all participants and their legal guardians before the study began. 
MR imaging
MRI exams were using a 3T magnet system (GE Discovery 750; General Electric Healthcare, Milwaukee, WI, United States), with a peak gradient amplitude of 50 mT/m and a 200 μsec time to peak. An eightelement body torso-array coil system was used. Before the spectroscopy acquisition, a T2-weighted image in the coronal plane (TR 1300, TE 125, FA 90°, slice thickness 6 mm, matrix 288 × 192) and a T1-weighted axial image (TR 4 ms/TE 1 ms, FA 60°, slice thickness 6 mm, matrix 288 × 192) were acquired. To quantify the hepatic fat fraction (HFF), an axial breath-hold low-flip angle, T1-weighted, 2D multiple-echo, spoiled gradient-echo (GRE) sequence (TR5.1/TE from 0.8 to 3.8, flip angle 5°, field of view 33 cm; section thickness, 10 mm; intersection gap, 0, matrix 128 × 128, acquisition time 2 × 17 s) was used was used. MRS was performed using one 20 mm × 20 mm × 20 mm voxels placed in segment Ⅵ-Ⅶ (as close as possible to the site of liver biopsy) and avoiding the artifact, major blood vessels and biliary ducts. All spectra were obtained in the stimulated echo acquisition mode (STEAM, TR 4000 ms), using a breath hold sequence with an acquisition time of approximately 24 s. Field homogeneity was automatically adjusted for each voxel. The T2 relaxation times of both metabolites were determined from their peak amplitudes at each echo time using an exponential least-squares fitting algorithm, and saturation bands were used [8] . For the quantification of subcutaneous and visceral adipose tissue (VAT and SAT), a 3D GRE T1-weighted sequence on an axial plane (TR4.1, TE 1.1, flip angle 15°, matrix 320 × 192, section thickness 6 mm reconstructed 3 mm, intersection gap 0) was acquired using the IDEAL imaging and Dixon method, which enabled the separation between water and fat components using the chemical shift MR technique.
Quantitative analysis
Images from multiple-echo GRE sequencing were subsequently analyzed with software provided by the manufacturer (Functool, GE Healthcare, Milwaukee, WI, United States); this procedure has been previously published [16] . A ROI measuring 2-3 cm in diameter was drawn at the same site as the voxel used for 1H-MRS to avoid extrahepatic fat and large vessels. Magnetic resonance spectra were reconstructed on a dedicated workstation using the SAGE Dev2 0017.1 software (General Electric Healthcare, Milwaukee, WI, United States). Raw data were zero-filled once, and no filter was used. Spectra were referenced to residual water and the dominant methylene lipid (-CH3 and -CH2) peak at δ 4.8-5.2 and δ 0.9-1.1 and 1.3-1.6 and 2.1-2.3, respectively. The fat fraction percentage (FF) was defined as follows: FF = FA/(FA + WA) x 100, where FA is the area under the fat peak and WA is the area under the water peak. The fat-only dataset from the T1-weighted sequence was transferred to a personal computer and analyzed using commercially available software (Slice-O-Matic; Tomovision Inc, Montreal Canada), the procedure for which has been described elsewhere [17, 18] . Briefly, SAT and VAT were calculated from 5 images extending from 5 cm below L4-L5 to 15 cm above L4-L5. A free-form ROI and manual thresholding were used to select tissue of fat within the subcutaneous and visceral adipose tissue ( Figure 1 ).
Histopathologic analysis
With ultrasound guidance and within two weeks of the MR examination, a percutaneous needle liver biopsy was performed using an 18-gauge needle, with the patients under local anesthesia. To obtain an adequate sample, biopsy specimens were obtained twice from all patients at two different sites in the right hepatic Institute Inc., Cary, NC, United States).
RESULTS
The clinical characteristics of the study population and control group are presented in Table 1 . Of the 27 patients who underwent liver biopsy, 11 (40.7%) children demonstrated grade 1 steatosis, 9 (33.3%) children demonstrated grade 2 and 7 (26%) demonstrated grade 3 (mean, 43.3% ± 26; range, 10%-90%). The mean lipid content for MRS was 30% ± 18 (median, 30%; range, 5%-66%), whereas the MRI-PDFF mean fat fraction was 11% ± 7 (median, 10%; range, 1%-33%) (Figure 2 ). The following HFF values were recorded in the control group: MRS (mean, 4.4% ± 2.5; median, 4%; range, 0.8%-13%) and MRI-PDFF (mean, 2.5 ± 2; median, 1.9%; range, 0.7%-11%).
The ROC curve analysis suggested a cut-off value of 6% for MRS to discriminate between patients with and without steatosis (sensitivity, 92.6%; specificity, 95.7%; 6 false positive calls); conversely, MRI-PDFF suggested a cut-off value of 3.5% (sensitivity, 89%; specificity, 88%; 4 false positive calls) (Figure 3) .
For MR spectroscopy, compared with the histology results, the Pearson test revealed a correlation of 0.68, (P = 0.0001) MRI-PDFF showed slightly lower values of 0.63, 0 (P = 0.0005).
Excellent correlation was reported between the MR techniques (ρ 0.81, P < 0.0001). Bland Altman plot reveals all points within were within the 95% limit of agreement, a possible bias encountered in the evaluation of MR-PDFF at medium and high level of hepatic steatosis (Figure 4) . lobe (Ⅵ and Ⅶ segments). Liver specimens that were at least 1.5 cm in length and contained at least 10-11 complete portal tracts were considered to be adequate for histological assessment. Liver steatosis was determined by estimating the percentage of fatcontaining hepatocytes on hematoxylin-eosin-stained specimens. The grading system for liver steatosis was based on the NASH Clinical Research Network criteria [19] : grade 0, less than 5% steatosis; grade 1, 6%-33% steatosis; grade 2, 34%-66% steatosis; and grade 3, greater than 66% steatosis. The grading system incorporates the accepted normal value for histopathologic liver fat, which is less than 5%, and it is the standard applied in the clinical assessment of severity of liver steatosis by hepatologists and gastroenterologists.
Statistical analysis
To estimate the proper sample size in the correlation between the MR imaging and liver biopsy, a power analysis was conducted, considering a coefficient correlation of 0.6, α error= 0.05 and power 1-β = 0.90; the number of subjects was 21. Receiver operating characteristic (ROC) curve analysis was used to determine the best cut-off values for MRS and MRI-PDHFF between the control group and children with NAFLD. The Pearson correlation coefficientwas calculated among histology, MRS and MRI-PDHFF We also estimated agreement by using the 95% limit-ofagreement method developed by Bland and Altman [20] . An analysis of the study population and control groups was performed to determine the median ± SD, and comparisons were made using the Mann-Whitney U test. Multivariate analysis of the continuous variables was performed to evaluate which variables were useful for predicting liver steatosis. A P value less than 0.05 was considered to indicate significant difference. Statistical analysis was performed using the MedCalc Software (V.13.1.2, Acacialaan 22 m 8400, Onsted, Belgium), except for the multivariate analysis, which was calculated using the JMP software (JMP.11, SAS 
DISCUSSION
Our results suggest that MRS is an accurate, noninvasive diagnostic technique for quantifying liver steatosis in a pediatric population and that MRI-PDFF is a feasible alternative technique. For MRS, the same cut-off value of 5% can be used to diagnosis liver steatosis in adolescents and adults; in contrast, when MRI-PDFF is used to quantify liver steatosis, a cutoff value of 3.5% is more appropriate. For clinical and morphologic analyses, the BMI, VAT, SAT and insulin levels should be jointly considered promising tools for predicting liver steatosis.
In a pediatric population, precise measurement of the degree of liver steatosis is of clinical interest because it has demonstrated an association with subclinical signs of atherosclerosis and changes in myocardial functions [21] [22] [23] [24] . At present, no laboratory test can be used for the non-invasive quantification of liver steatosis, and ALT values may be elevated only in severe cases [25] . Although our analysis reported significantly higher levels of ALT and insulin in pre- 
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dicting liver steatosis, only in severe cases were the results beyond normal ranges. Anthropometry data revealed significantly higher BMI, SAT and VAT values in children with NAFLD, as previously described in the literature [26, 27] ; unfortunately, multivariate analysis demonstrated only moderate to good values in predicting liver steatosis (range, 0.80 -0.50).
Among the imaging modalities, MRS can provide a reliable estimation of the weight fraction of liver fat content, and it is now considered to be the most accurate non-invasive method; for these reasons, it is used extensively in published reports [28] [29] [30] [31] [32] . In addition, in our experience, MRS demonstrated excellent correlation with liver biopsy, with good concordance. However, MRS is an expensive and primarily research-based tool that is not always available [33, 34] . MRI-PDFF has been proposed as a feasible and simple alternative method for quantifying liver steatosis [10, 11, [35] [36] [37] . Our data demonstrated good correlation between histology. However a probable error should be develop in the differentiation between moderate and high grade of steatosis: this limit of chemical shift technique is attributed to the presence of both water and fat (fat-water signal dominance ambiguity) in the single voxel and it is not of clinical relevance for patients treatment and managment [38, 39] . MR-PDFF suggests a lower threshold (3.5%) to define hepatic steatosis in children, in agreement with a recent publication by Rehm et al [40] . Our multiple-echo sequence has several advantages over MRS. First, the acquisition time is short, easily fitting within a breath hold. Second, the fat content can be measured throughout the liver instead of in only one voxel or a few voxels; this point is of major importance because fat distribution is often heterogeneous. Third, no spatial miss-registration errors occur because the OP and IP images are acquired simultaneously. Fourth, post-processing is considerably easier and faster than with MRS.
Some study limitations should be noted. First, the site-to-site reproducibility of our technique was evaluated only in segment Ⅶ. Second, our control group did not have histologically confirmed healthy livers because it would have been unethical to subject normal individuals to liver biopsy assessments. Thirdly, the three parameters (MRS, MR-PDFF and histology) tested in our study assess different aspects of steatosis. Histology reveals the percentage of hepatocytes that contain vesicles of fat, MR-PDFF determines the proportion of mobile protons contained within fat molecules and MRS shows the peaks of methyl and methylene (-CH2 and CH3) protons in the triglyceride molecule.
Finally, Bland-Altman plot analysis demonstrates a difficulty of MR-PDFF in the differentiation between moderate to severe steatosis; however this drawback has not clinical relevance becasuse treatment and managmetn of patients is quite similar.
In conclusion, MRS was confirmed as the most accurate non-invasive method for quantifying liver steatosis in obese children.
Multiple-echo gradient-echo MR sequence may also be an easily and rapidly performed technique used to quantify liver steatosis in a pediatric population; this technique demonstrated excellent agreement with MRS and should be considered as reference standard in longitudinal studies or clinical trials. Together, BMI, VAT, SAT and insulin measurements provide the most powerful test for predicting liver steatosis. Further studies should be conducted to better match data from histological and MRI analyses and to establish MRI thresholds for different grades of steatosis. 
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Background
Non-alcoholic fatty liver disease (NAFLD) is emerging as a leading cause of chronic liver disease in children and adolescents, with a prevalence in the general population ranging from 3%-10% in normal weight children and 80% in obese children. Children with NAFLD are usually asymptomatic and garner clinical attention because of elevated liver enzymes or fatty liver being observed during an ultrasound examination.
Research frontiers
A recently published paper suggested similar fat-storage between overweight children and adults, and the study proposed the same cut-off value for normal and pathologic storage.
Innovations and breakthroughs
Body mass index, subcutaneous and visceral adipose tissue and insulin measurements provide the most powerful test for predicting liver steatosis.
Applications
This study should be conducted to better match data from histological and MRI analyses and to establish MRI thresholds for different grades of steatosis.
